The Connecticut Bioscience Pipeline program, a partnership between Connecticut Innovations, the University of Connecticut, Quinnipiac University and Yale University, has launched the first of four open application periods in search of new ideas that can one day become investable business ventures in the medical devices, drug delivery, diagnotics and health IT industries.

Eligible projects can qualify for up to $30,000 per team over 12 months to be used for business strategy, market definition and prototyping, and proof-of-concept activities.

Applications for this first round must be submitted by 5:00 p.m. ET on April 26